• <p id="1001x"></p>
  • <pre id="1001x"></pre>
    <table id="1001x"></table>

      FRONTIER BIOTECHNOLOGIES Inc.

      Products

      Frontier Biotechnologies Inc.(Nanjing)
      Home>Products

      FB3001

      • 2018-09-25  14:55:25

      FB3001, a new transdermal topical patch, is a musculoskeletal joint pain treatment, currently under clinical development. Through collaboration with ABsize, FB3001's Phase II clinical trial for treating lower back pain has been completed in the United States. The clinical data demonstrates that FB3001 provides superior pain relief for patients with chronic lower back pain compared to placebo. FB3001 minimizes systemic drug exposure with limited side effects that are common in oral therapies. Frontier Biotech also filed an Investigational New Drug (IND) application for FB3001 in China and was granted approval by the National Medical Products Administration (NMPA) in March 2019. A Phase I bridging pharmacokinetic study has been completed.


      Develop Innovative Therapies to Better Human Lives

      亚洲电影av-手机版在线播放,最新av影片在线直播在线,手机av看片资源网